Abbott (NYSE: ABT) has another integration on the way for an upcoming sensor, with Ypsomed and CamDiab the latest companies to enter into an agreement.
Our sister site, Drug Delivery Business News, reports today that the companies plan to pair their mylife Loop automated insulin delivery system with the Abbott dual glucose-ketone sensor, currently under development.
Ypsomed and CamDiab join three other companies set to pair their pumps with the sensor after Abbott recently agreed to implement integrations with automated insulin delivery systems offered by Sequel Med Tech, Tandem Diabetes Care and Beta Bionics,
mylife Loop combines the adaptive mylife CamAPS FX app, the mylife YpsoPump insulin pump and a CGM sensor. It currently pairs with the FreeStyle Libre 3 or FreeStyle Libre 3 Plus from Abbott and the Dexcom G6. The companies market the offering in most European countries, Canada, Australia and New Zealand. They recently announced an expanded rollout for the system with an app for the iPhone.
Get the full story at our sister site, Drug Delivery Business News.
